Allal BC - Search Results

1

Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis.

Dalenc F, Doisneau-Sixou SF, Allal BC, Marsili S, Lauwers-Cances V, Chaoui K, Schiltz O, Monsarrat B, Filleron T, Renée N, Malissein E, Meunier E, Favre G, Roché H. Dalenc F, et al. Among authors: allal bc. Clin Cancer Res. 2010 Feb 15;16(4):1264-71. doi: 10.1158/1078-0432.CCR-09-1192. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145184 Clinical Trial.

2

Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma.

Thomas F, Rochaix P, Benlyazid A, Sarini J, Rives M, Lefebvre JL, Allal BC, Courbon F, Chatelut E, Delord JP. Thomas F, et al. Among authors: allal bc. Clin Cancer Res. 2007 Dec 1;13(23):7086-92. doi: 10.1158/1078-0432.CCR-07-1370. Clin Cancer Res. 2007. PMID: 18056187 Clinical Trial.

3

Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.

Vergez S, Delord JP, Thomas F, Rochaix P, Caselles O, Filleron T, Brillouet S, Canal P, Courbon F, Allal BC. Vergez S, et al. Among authors: allal bc. Clin Cancer Res. 2010 Sep 1;16(17):4434-45. doi: 10.1158/1078-0432.CCR-09-2795. Epub 2010 Jul 26. Clin Cancer Res. 2010. PMID: 20660574

4

Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptors.

Zindy P, Bergé Y, Allal B, Filleron T, Pierredon S, Cammas A, Beck S, Mhamdi L, Fan L, Favre G, Delord JP, Roché H, Dalenc F, Lacroix-Triki M, Vagner S. Zindy P, et al. Cancer Res. 2011 Jun 15;71(12):4068-73. doi: 10.1158/0008-5472.CAN-11-0420. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498638

5

An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.

Arellano C, Allal B, Goubaa A, Roché H, Chatelut E. Arellano C, et al. J Pharm Biomed Anal. 2014 Nov;100:254-261. doi: 10.1016/j.jpba.2014.07.033. Epub 2014 Aug 4. J Pharm Biomed Anal. 2014. PMID: 25173109

6

A fast UPLC-HILIC method for an accurate quantiﬁcation of dendrogenin A in human tissues.

Soulès R, Audouard-Combe F, Huc-Claustre E, de Medina P, Rives A, Chatelut E, Dalenc F, Franchet C, Silvente-Poirot S, Poirot M, Allal B. Soulès R, et al. J Steroid Biochem Mol Biol. 2019 Nov;194:105447. doi: 10.1016/j.jsbmb.2019.105447. Epub 2019 Aug 12. J Steroid Biochem Mol Biol. 2019. PMID: 31415823

7

Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamide.

Valentin T, Lambert M, Chaltiel L, Allal B, Mseddi M, Yakoubi M, Chevreau C, Toulmonde M, Firmin N, Filleron T, Chatelut E. Valentin T, et al. Eur J Pharm Sci. 2023 Jun 1;185:106420. doi: 10.1016/j.ejps.2023.106420. Epub 2023 Mar 5. Eur J Pharm Sci. 2023. PMID: 36882147 Free article.

8

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation.

Balin-Gauthier D, Delord JP, Pillaire MJ, Rochaix P, Hoffman JS, Bugat R, Cazaux C, Canal P, Allal BC. Balin-Gauthier D, et al. Among authors: allal bc. Br J Cancer. 2008 Jan 15;98(1):120-8. doi: 10.1038/sj.bjc.6604134. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182978 Free PMC article.

9

Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model.

Delord JP, Quideau S, Rochaix P, Caselles O, Couderc B, Hennebelle I, Courbon F, Canal P, Allal BC. Delord JP, et al. Among authors: allal bc. Br J Cancer. 2010 Jun 29;103(1):61-72. doi: 10.1038/sj.bjc.6605699. Epub 2010 Jun 1. Br J Cancer. 2010. PMID: 20588279 Free PMC article.

10

Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.

Le Louedec F, Alix-Panabières C, Lafont T, Allal BC, Garrel R, Digue L, Guigay J, Cupissol D, Delord JP, Lallemant B, Alfonsi M, Aubry K, Mazel M, Becher F, Perriard F, Chatelut E, Thomas F. Le Louedec F, et al. Among authors: allal bc. Br J Clin Pharmacol. 2019 Jun;85(6):1357-1366. doi: 10.1111/bcp.13907. Epub 2019 Apr 13. Br J Clin Pharmacol. 2019. PMID: 30811063 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters